Anti-Ovary Antibodies by Indirect Fluorescent Antibody (IFA) (RDL)
Use
Anti-ovary antibodies are present in 78% of patients with premature ovarian failure and Addisons disease.
Special Instructions
This test currently is not approved for use in New York state. Ensure serum is separated from cells within one hour of collection and transferred to a plastic transport tube before shipping to avoid delays. Separate frozen specimens for multiple tests when requested.
Limitations
The volume requirement for this test is critical as the minimum volume does not allow for repeat testing. Specimens must be handled correctly to avoid rejection due to hemolysis, contamination, or inappropriate specimen type. The stability of the sample over multiple freeze/thaw cycles is limited to one.
Methodology
Immunoassay (Indirect fluorescent antibody (IFA))
Biomarkers
LOINC Codes
- 25725-3
- 25725-3
Result Turnaround Time
7-14 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.3 mL
Container
Red-top tube or gel-barrier tube
Collection Instructions
Separate serum from cells within one hour of collection. Transfer to a plastic transport tube before shipping.
Storage Instructions
Refrigerate or freeze.
Causes for Rejection
Grossly hemolyzed; bacterial contamination; lipemic specimen; icteric specimen; non-serum specimen types
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 14 days |
| Frozen | 60 days |